";s:4:"text";s:3795:" MAXALT is available as a traditional tablet (MAXALT) and as an orally disintegrating tablet (MAXALT-MLT).MAXALT and MAXALT-MLT are used to treat migraine attacks with or without aura in adults and in children 6 to 17 years of age.MAXALT is not to be used to prevent migraine attacks.MAXALT is not for the treatment of hemiplegic or basilar migraines.It is not known if MAXALT is safe and effective for the treatment of cluster headaches.It is not known if taking more than 1 dose of MAXALT in 24 hours is safe and effective in children 6 to 17 years of age.It is not known if MAXALT is safe and effective in children under 6 years of age.Talk to your doctor before taking this medicine if you have any of the conditions listed above or if you are not sure if you take any of these medicines.MAXALT and other medicines may affect each other causing side effects.
Associated symptoms of nausea, photophobia, and phonophobia and maintenance of response up to 24 hours postdose were evaluated. HIV super disease was chiefly seen in high hazard populations.it is identified with the constant viral diseases, for example, cytomegalovirus and Epstein-Barr infection. Some people were infected with HIV after receiving a blood transfusion or organ transplant from an HIV-infected donor. Orally disintegrating tablets are packaged in a blister within an outer aluminum pouch and patients should not remove the blister from the outer pouch until just prior to dosing. Geriatric use: Clinical trials of Viread® did not include sufficient numbers of subjects aged 65 years and over. MAXALT should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.In a general reproductive study in rats, birth weights and pre- and post-weaning weight gain were reduced in the offspring of females treated prior to and during mating and throughout gestation and lactation with doses of 10 and 100 mg/kg/day. For more details visit our Price Match page. The safety of treating, on average, more than four headaches in a 30-day period has not been established.Dosing in pediatric patients is based on the patient’s body weight. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. Because studies are conducted at different times, with different samples of patients, by different investigators, employing different criteria and/or different interpretations of the same criteria, under different conditions (dose, dosing regimen, etc.
The recommended dose of MAXALT is 5 mg in patients weighing less than 40 kg (88 lb), and 10 mg in patients weighing 40 kg (88 lb) or more.The efficacy and safety of treatment with more than one dose of MAXALT within 24 hours in pediatric patients 6 to 17 years of age have not been established.For MAXALT-MLT Orally Disintegrating Tablets, administration with liquid is not necessary. Medication overuse headache may present as migraine-like daily headaches, or as a marked increase in frequency of migraine attacks. The pro virus enter into cell, the cell was activated it converts into messenger RNA by using human enzymes. HIV is Human Immunodeficiency Virus is one such retrovirus that causes AIDS (Acquired Immunodeficiency Syndrome).Journal of HIV & Retro virus is an open access peer reviewed journal that covers the prevention and treatment techniques of HIV.